Calidi Biotherapeutics, Inc. (CLDI) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Calidi Biotherapeutics, Inc. (CLDI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.4M, listed on AMEX, employing roughly 28 people, carrying a beta of 1.38 to the broader market. Calidi Biotherapeutics, Inc. Led by Eric E. Poma, public since 2021-11-01.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for CLDI as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →